UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer Patients

Autoimmunity reviews, 2016-05, Vol.15 (5), p.477-483

2016

Volltextzugriff (PDF)

Melanoma circulating tumor cells: Benefits and challenges required for clinical application

Cancer letters, 2018-06, Vol.424, p.1-8

2018

Volltextzugriff (PDF)

Prevalence of malnutrition in children under five and school-age children in Milot Valley, Haiti

Public health (London), 2014-12, Vol.128 (12), p.1094-1098

2014

Volltextzugriff (PDF)

82P HLA-I heterozygosity and increased incidence of immune related toxicity among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

Annals of oncology, 2021-09, Vol.32, p.S391-S392

2021

Volltextzugriff (PDF)

224P Germline HLA-I/II is not associated with clinical outcome but the absence of HLA-A01 or the presence of HLA-B27 supertypes were correlated with improved clinical outcome among patients with NSCLC treated with pembrolizumab in combination with chemotherapy

Annals of oncology, 2023-10, Vol.34, p.S271-S271

2023

Volltextzugriff (PDF)

340P Advanced lung cancer inflammation index (ALI) association with increased risk of immune related adverse events (irAE) among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

Annals of oncology, 2022-11, Vol.33, p.S1575

2022

Volltextzugriff (PDF)

1086P Advanced lung cancer inflammation index (ALI) association with increased risk of immune-related adverse events (irAEs) among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

Annals of oncology, 2022-09, Vol.33, p.S1049

2022

Volltextzugriff (PDF)

LBA68 Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

Annals of oncology, 2021-09, Vol.32, p.S1344-S1344

2021

Volltextzugriff (PDF)

1478P Circulating pre-treatment T-Cell receptor repertoire as a predictive biomarker in non-small cell lung cancer patients treated with pembrolizumab

Annals of oncology, 2023-10, Vol.34, p.S836-S836

2023

Volltextzugriff (PDF)

1730P The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1

Annals of oncology, 2022-09, Vol.33, p.S1327-S1328

2022

Volltextzugriff (PDF)

1155P Application of novel machine learning to predict immunotherapy related toxicities for metastatic melanoma patients from baseline 18F-FDG PET/CT scans

Annals of oncology, 2023-10, Vol.34, p.S689-S690

2023

Volltextzugriff (PDF)

130P Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

Annals of oncology, 2022-09, Vol.33, p.S597

2022

Volltextzugriff (PDF)

1053P Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma

Annals of oncology, 2021-09, Vol.32, p.S879-S879

2021

Volltextzugriff (PDF)

A standardised protocol for the evaluation of small extracellular vesicles in plasma by imaging flow cytometry

Journal of immunological methods, 2019-05, Vol.468, p.61-66

2019

Volltextzugriff (PDF)

PD-L1 expression on pre-treatment circulating tumour cells, but not serum VEGF, is predictive of response to pembrolizumab in melanoma

Annals of oncology, 2018-10, Vol.29, p.viii24-viii25

2018

Volltextzugriff (PDF)

Circulating pre-treatment T-Cell Receptor repertoire as a predictive biomarker in advanced or metastatic non-small cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy

ESMO open, 2023-12, Vol.8 (6), p.102066-102066, Article 102066

2023

Volltextzugriff (PDF)

Ponderal index is a poor predictor of in utero growth retardation

BJOG : an international journal of obstetrics and gynaecology, 2004-02, Vol.111 (2), p.113-119

2004

Volltextzugriff (PDF)

Teaching elderly patients about their medication before discharge from hospital - the role of the first level nurse

Gray, E.S

1997

Volltextzugriff (PDF)

Clinical pharmacy services in oncology clinics

Journal of oncology pharmacy practice, 1999-01, Vol.5 (1), p.49-54

1999

Volltextzugriff (PDF)

A CLINICAL, SEROLOGICAL AND NEUROPHYSIOLOGICAL STUDY OF RESTLESS LEGS SYNDROME IN RHEUMATOID ARTHRITIS

Rheumatology (Oxford, England), 1994, Vol.33 (1), p.60-63

1994

Volltextzugriff (PDF)

Paget's disease of bone and unvaccinated dogs

Bone (New York, N.Y.), 1996-07, Vol.19 (1), p.47-50

1996

Volltextzugriff (PDF)

Establishing a hospital specialist osteoporosis service

Osteoporosis international, 1996-01, Vol.6 Suppl 2 (S2), p.24-25

Gray, R E

1996

Volltextzugriff (PDF)

The Mechanism of Muscle Calcification

Rheumatology (Oxford, England), 1990-04, Vol.29 (2), p.155-156

GRAY, R. E. S

1990

Volltextzugriff (PDF)

Long-term follow-up observations on treatment in Paget's disease of bone

Clinical orthopaedics and related research, 1987-04 (217), p.99-125

1987

Volltextzugriff (PDF)

REPORT OF SENIOR REGISTRARS' UK TRAVELLING FELLOWSHIP LONDON, 22–-26 OCTOBER 1990

Rheumatology (Oxford, England), 1991-12, Vol.30 (6), p.405-406

1991

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(12)
Archives Of Clinical Neuropsychology
(6)
Icarus
(6)
Nuclear Physics. B
(6)
Gynecologic Oncology
(4)
Toxicology In Vitro
(4)
Advances In Water Resources
(3)
Bmj
(3)
Bmj. British Medical Journal
(3)
Bone
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autoantibody Production in Cancer—The Humoral Immune Response toward Autologous Antigens in Cancer Patients

Melanoma circulating tumor cells: Benefits and challenges required for clinical application

Prevalence of malnutrition in children under five and school-age children in Milot Valley, Haiti

82P HLA-I heterozygosity and increased incidence of immune related toxicity among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

224P Germline HLA-I/II is not associated with clinical outcome but the absence of HLA-A01 or the presence of HLA-B27 supertypes were correlated with improved clinical outcome among patients with NSCLC treated with pembrolizumab in combination with chemotherapy

340P Advanced lung cancer inflammation index (ALI) association with increased risk of immune related adverse events (irAE) among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

1086P Advanced lung cancer inflammation index (ALI) association with increased risk of immune-related adverse events (irAEs) among non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

LBA68 Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy

1478P Circulating pre-treatment T-Cell receptor repertoire as a predictive biomarker in non-small cell lung cancer patients treated with pembrolizumab

1730P The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1

1155P Application of novel machine learning to predict immunotherapy related toxicities for metastatic melanoma patients from baseline 18F-FDG PET/CT scans

130P Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)

1053P Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma

A standardised protocol for the evaluation of small extracellular vesicles in plasma by imaging flow cytometry

PD-L1 expression on pre-treatment circulating tumour cells, but not serum VEGF, is predictive of response to pembrolizumab in melanoma

Circulating pre-treatment T-Cell Receptor repertoire as a predictive biomarker in advanced or metastatic non-small cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy

Ponderal index is a poor predictor of in utero growth retardation

Teaching elderly patients about their medication before discharge from hospital - the role of the first level nurse

Clinical pharmacy services in oncology clinics

A CLINICAL, SEROLOGICAL AND NEUROPHYSIOLOGICAL STUDY OF RESTLESS LEGS SYNDROME IN RHEUMATOID ARTHRITIS

Paget's disease of bone and unvaccinated dogs

Establishing a hospital specialist osteoporosis service

The Mechanism of Muscle Calcification

Long-term follow-up observations on treatment in Paget's disease of bone

REPORT OF SENIOR REGISTRARS' UK TRAVELLING FELLOWSHIP LONDON, 22–-26 OCTOBER 1990

Suchergebnisse filtern